论文部分内容阅读
目的探讨中西医结合治疗矽肺患者的有效性和安全性。方法选取我院收治的65例矽肺患者,根据治疗方法不同分为对照组33例(口服氨茶碱,抗感染和必要时吸氧等常规治疗)和治疗组32例(在常规治疗的基础上给予中药“自拟克矽汤”水煎服治疗)。比较两组患者的肺功能变化情况、治疗总有效率和不良反应发生率的差异。结果治疗后所有患者的肺活量(VC)、第1秒用力呼气容积(FEV1)和用力肺活量(FVC)等均得到不同程度的改善,治疗组患者较对照组改善更明显(P<0.05);治疗组的治疗总有效率为93.9%,显著高于对照组的63.6%(P<0.05);两组患者均无不良反应发生,不良反应发生率比较差异无统计学意义(P>0.05)。结论采用中西医结合治疗矽肺患者安全有效,能显著改善肺功能,提高临床疗效。
Objective To investigate the efficacy and safety of integrated traditional Chinese and western medicine in the treatment of patients with silicosis. Methods Sixty-five patients with silicosis admitted to our hospital were selected and divided into control group (oral aminophylline, anti-infection, oxygen inhalation and other conventional treatment if necessary) and treatment group (according to the different treatment methods), 32 patients Give medicine “self g Sifu ” Shuijianbi treatment). The changes of pulmonary function, the total effective rate of treatment and the incidence of adverse reactions were compared between the two groups. Results After treatment, the vital capacity (VC), forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) in all patients were improved to some extent. The treatment group improved more obviously than the control group (P <0.05). The total effective rate of the treatment group was 93.9%, which was significantly higher than that of the control group (63.6%, P <0.05). No adverse reactions occurred in both groups, and the incidence of adverse reactions was no significant difference (P> 0.05). Conclusion The treatment of silicosis with integrated traditional Chinese and western medicine is safe and effective, which can significantly improve pulmonary function and improve clinical efficacy.